StoppedWithdrawn before enrollingSponsor's reason: never obtained fundingShow 7 more changesShow less
Primary completion pushed from Dec 2026 to Dec 2029
Lead sponsor: Boston Children's Hospital to Boston Children's Hospital
Enrollment target: estimated 168 to confirmed 0
Start date: Jan 2025 to Jan 2027
Study completion pushed from Dec 2026 to Jul 20, 2030
Eligibility criteria expanded, about 10 words
Secondary endpoints: details revised at 3 of 4 entries
NotablePrimary and study completion dates: Dec 2025 to Dec 2026
Start date: Jan 2023 to Jan 2025
v6
NotablePrimary and study completion dates: Dec 2023 to Dec 2025
Start date: Jan 2021 to Jan 2023
v5
NotablePrimary and study completion dates: Dec 2020 to Dec 2023
Start date: Jan 2020 to Jan 2021
v4
NotableStart date: Jan 2019 to Jan 2020v3
MinorSecondary endpoints: details revised at 1 of 4 entriesv2
MinorStudy First Submitted
Stopped: an ongoing trial was terminated, suspended or withdrawn.
Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The objectives of this study are to increase families' understanding of eczema and improve eczema management in the primary care setting. The investigators plan to create an educational video for families providing general information about eczema as well as instructions about good skincare management and common treatments. The investigators will conduct a randomized controlled trial of the plan in the primary care clinic at Boston Children's Hospital. Specifically, the investigators aim to (1) decrease eczema severity (2) improve patient and family quality of life (QOL) and (3) increase parental knowledge about eczema and eczema management.